- DAY 1 2024.10.21
- DAY 2 2024.10.22
Haemato-oncology
21 October 2024 • 16:00
-17:20 • London Hall
Thematic scope
- Changes to medicines programmes, including optimization of guidelines for the treatment of chronic lymphocytic leukemia and multiple myeloma
- Access to treatment for patients with transfusion-dependent, low-risk myelodysplastic neoplasms
- CAR-T in the treatment of plasmocytic myeloma and lymphoma